AbbVie Inc. (NYSE:ABBV) is one of the 10 undervalued blue chip stocks analysts recommend for smart investing. On June 18, the ...

ABBV's growing oncology portfolio, now spanning five therapies, is helping offset Imbruvica's sales decline and boost ...

Pedro Valencia, VP, asset strategy leadership, oncology, AbbVie, explains how the company is advancing Temab-A across multiple tumor types targeting c-Met, with the goal of establishing it as a ...

Drug company shares are down amid President Donald Trump’s assault on the industry, but some in Congress see value.

Functional MRI studies have established that subjective feelings of pain and fatigue have objective correlates in terms of ...

Congressional lawmakers are trading millions in pharmaceutical stocks as the Trump administration vies to overhaul the ...

CAR T-cell therapy targeting B-cell maturation antigen (BCMA) has become a game changer for patients with relapsed or ...

Illinois-based Abbott Laboratories required job applicants to disclose their family medical histories in violation of the state’s Genetic Information Privacy Act, a proposed federal class action said.

Licensing of innovator oligonucleotide drugs for central nervous system (CNS) indications surged 339% in 2024, jumping from ...

According to a new comprehensive report from The Insight Partners, the global ovarian cancer drugs market is observing ...

Historic changes are afoot for pharma as China gains ground on U.S. production. The pharma industry is projected to see ...

The ADDF’s CFO discusses the areas that foundation is raising money for and how its reacting to the current economic ...